FDA, DEA call on drugmakers to boost manufacturing amid ongoing shortage of prescription stimulants | CNN

Amid an ongoing shortage of prescription stimulants in the US, federal agencies are calling on drugmakers to boost manufacturing and on health care providers to closely monitor prescribing practices.

           

https://www.facebook.com/cnn/posts/676030131056308

Michael Smith Adderall is a prescription medication that contains a combination of two central nervous system stimulants: amphetamine and dextroamphetamine. It is primarily used to treat attention deficit hyperactivity disorder (ADHD) and narcolepsy. These stimulants increase the levels of certain neurotransmitters, such as dopamine and norepinephrine, in the brain, which can help improve focus and attention in individuals with ADHD.

Methamphetamine, commonly known as meth, is a potent central nervous system stimulant that is chemically related to amphetamine. While Adderall contains a mixture of amphetamine salts, methamphetamine is a single compound that is structurally similar but has some distinct differences. Methamphetamine has a higher potential for abuse and is classified as a Schedule II controlled substance due to its high addictive properties and potential for misuse.




+